Trastorno bipolar y trastorno por uso de sustancias. Estudio Madrid sobre prevalencia de patología dual
DOI:
https://doi.org/10.20882/adicciones.782Palabras clave:
patología dual, prevalencia, trastorno bipolar, alcohol, cocaína, cannabis, opiáceosResumen
La comorbilidad entre trastorno bipolar y trastorno por uso de sustancias (TUS) es de las más relevantes dentro del espectro de la patología dual por su prevalencia y sus repercusiones evolutivas y sociosanitarias. Nuestro objetivo fue estudiar las características de los pacientes con diagnóstico de trastorno bipolar y trastorno por uso de sustancias procedentes del Estudio Madrid sobre prevalencia de patología dual en sujetos en tratamiento en el servicio sanitario público. La muestra procede de pacientes en tratamiento en las redes públicas de salud mental y de tratamiento para las adicciones de la Comunidad de Madrid. Los sujetos fueron evaluados con la entrevista Mini International Neuropsychiatric Interview (MINI) para el diagnóstico de los trastornos mentales y con la escala Personality Disorder Questionnaire (PDQ) para el diagnóstico de los trastornos de personalidad. De los 837 pacientes incluidos, 174 tenían un diagnóstico a lo largo de la vida de trastorno bipolar, 83 con trastorno bipolar tipo I y 91 del tipo II. La mayoría de ellos tenían algún diagnóstico de TUS. En la red de salud mental, de los 208 participantes, 21 tenían un diagnóstico de trastorno bipolar, de estos el 13 (61.9%) tenían un diagnóstico de TUS y se consideraron duales, mientras que en el resto de los pacientes de salud mental el 33.2% tenían un diagnóstico comórbido de TUS (p = 0.03). En los centros de drogas, de los 629 pacientes valorados, un 24.3% (n = 153) tenían un diagnóstico de trastorno bipolar. El subgrupo de pacientes con trastorno bipolar tenía mayor prevalencia de adicción al alcohol y a la cocaína que el resto de los pacientes. Además, la edad de inicio en el consumo de alcohol era más precoz entre los adictos bipolares que entre los adictos no bipolares. Los bipolares duales era un subgrupo con mayor comorbilidad con trastornos de personalidad, otros trastornos mentales como trastornos de ansiedad y mayor riesgo de suicidio. Estos datos apoyan que el alcohol principalmente y la cocaína son las drogas más relacionadas con la presencia de un trastorno bipolar, pero al ser un estudio transversal no se pueden extraer conclusiones etiológicas.Citas
Amorim, P., Lecrubier, Y., Weiller, E., Hergueta, T. y Sheehan D. (1998). DSM-IV-R Psychotic Disorders: procedural validity of the Mini International Neuropsychiatric Interview (MINI). Concordance and causes for discordance with the CIDI. European Psychiatry, 13, 26-34. doi: 10.1016/S0924-9338(97)86748-X
Arias, F., Szerman, N., Vega, P., Mesias, B., Basurte, I., Morant, C., ... Babín, F. (2013a). Estudio Madrid sobre prevalencia y características de los pacientes con patología dual en tratamiento en las redes de salud mental y de atención al drogodependiente. Adicciones, 25, 118-127.
Arias, F., Szerman, N., Vega, P., Mesias, B., Basurte, I., Morant, C., ... Babin, F. (2013b). Abuso o dependencia al cannabis y otros trastornos psiquiátricos. Estudio Madrid sobre prevalencia de patología dual. Actas Españolas de Psiquiatría, 41, 123-130.
Bauer, M.S., Altshuler, L., Evans, D.R., Beresford, T., Williford, W.O. y Hauger, R. (2005). Prevalence and distinct correlates of anxiety, substance, and combined comorbidity in a multi-site public sector sample with bipolar disorder. Journal of Affective Disorders, 85, 301-315.
Calvo, N., Caseras, X., Gutierrez, F. y Torrubia, R. (2002). Spanish version of the personality diagnostic questionnaire-4+ (PDQ-4+). Actas Españolas de Psiquiatría, 30, 7–13.
Carmiol, N., Peralta, J.M., Almasy, L., Contreras, J., Pacheco, A., Escamilla, M.A., ... Glahn, D.C. (2014). Shared genetic factors influence risk for bipolar disorder and alcohol use disorders. European Psychiatry, 29, 282-287. doi: 10.1016/j.eurpsy.2013.10.001
Carrà, G., Bartoli, F., Crocamo, C., Brady, K.T. y Clerici, M. (2014). Attempted suicide in people with co-occurring bipolar and substance use disorders: systematic review and meta-analysis. Journal of Affective Disorders, 167, 125-135. doi: 10.1016/j.jad.2014.05.066
Cassidy, F., Ahearn, E.P. y Carroll, B.J. (2001). Substance abuse in bipolar disorder. Bipolar Disorders, 3, 181-188.
Cerullo, M.A. y Strakowski, S.M. (2007). The prevalence and significance of substance use disorders in bipolar type I and II disorder. Substance Abuse Treatment, Prevention, and Policy, 2, 29.
Comtois, K.A., Russo, J.E., Roy-Byrne, P. y Ries, R.K. (2004). Clinicians’ assessments of bipolar disorder and substance abuse as predictors of suicidal behavior in acutely hospitalized psychiatric inpatients. Biological Psychiatry, 56, 757-763.
Do, E.K. y Mezuk, B. (2013). Comorbidity between hypomania and substance use disorders. Journal of Affective Disorders, 150, 974-980. doi: 10.1016/j.jad.2013.05.023
Frank, E., Boland, E., Novick, D.M., Bizzarri, J.V. y Rucci, P. (2007). Association between illicit drug and alcohol use and first manic episode. Pharmacology, Biochemistry and Behavior, 86, 395-400.
Frye, M.A., Altshuler, L.L., McElroy, S.L., Suppes, T., Keck, P.E., Denicoff, K., ... Post, R.M. (2003). Gender differences in prevalence, risk, and clinical correlates of alcoholism comorbidity in bipolar disorder. American Journal of Psychiatry, 160, 883-889.
González-Pinto, A., Mosquera, F., Alonso, M., López, P., Ramírez, F., Vieta, E. y Baldessarini, R.J. (2006). Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment. Bipolar Disorders, 8, 618–624.
González-Pinto, A., Reed, C., Novick, D., Bertsch, J. y Haro, J.M. (2010). Assessment of Medication Adherence in a cohort of patients with bipolar disorder. Pharmacopsychiatry, 43, 263– 270. doi: 10.1055/s-0030-1263169
Grant, B.F., Stinson, F.S., Hasin, D.S., Dawson, D.A., Chou, S.P., Ruan, W.J. y Huang, B. (2005). Prevalence, correlates, and comorbidity of bipolar I disorder and axis I and II disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry, 66, 1205-1215.
Güclü, O., Şenormancı, Ö., Aydın, E., Erkıran, M. y Köktürk, F. (2014). Phenomenological subtypes of mania and their relationships with substance use disorders. Journal of Affective Disorders, 174, 569-573. doi: 10.1016/j.jad.2014.11.016
Hidalgo-Mazzei, D., Walsh, E., Rosenstein, L. y Zimmerman, M. (2015). Comorbid Bipolar Disorder and Borderline Personality Disorder and Substance Use Disorder. Journal of Nervous and Mental Disease, 203, 54-57. doi: 10.1097/NMD.0000000000000235
Himmelhoch, J.M., Mulla, D., Neil, J.F., Detre, T.P. y Kupfer, D.J. (1976). Incidence and significance of mixed affective states in a bipolar population. Archives of General Psychiatry, 33,1062-1066.
Keller, M.B., Lavori, P.W., Coryell, W., Andreasen, N.C., Endicott, J., Clayton, P.J., ... Hirschfeld, R.M. (1986). Differential outcome of pure manic, mixed/cycling, and pure depressive episodes in patients with bipolar illness. The Journal of the American Medical Association, 255, 3138-3142.
Kessler, R.C., Nelson, C.B., McGonagle, K.A., Edlund, M.J., Frank, R.G. y Leaf, P.J. (1996). The epidemiology of cooccurring addictive and mental disorders: Implications for prevention and service utilization. American Journal of Orthopsychiatry, 66, 17–31.
Kessler, R.C., Rubinow, D.R., Holmes, C., Abelson, J.M. y Zhao, S. (1997). The epidemiology of DSM-III-R bipolar I disorder in a general population survey. Psychological Medicine, 27, 1079-1089.
Lagerberg, T.V., Larsson, S., Sundet, K., Hansen, C.B., Hellvin, T., Andreassen, O.A. y Melle, I. (2010). Treatment delay and excessive substance use in bipolar disorder. Journal of Nervous and Mental Disease, 198, 628-633. doi: 10.1097/NMD.0b013e3181ef3ef4
Lecrubier, Y., Sheehan, D., Weiller, E., Amorim, P., Bonora, L.I. y Sheehan, K. (1997). The MINI International Neuropsychiatric Interview (MINI) A short diagnostic structured interview: Reliability and validity according to the CIDI. European Psychiatry, 12, 224-231.
Levin, F.R. y Hennessy, G. (2004). Bipolar disorder and substance abuse. Biological Psychiatry, 56, 738-748.
Mantere, O., Melartin, T.K., Suominen, K., Rytsälä, H.J., Valtonen, H.M., Arvilommi, P., Leppämäki, S. y Isometsä, E.T. (2006). Differences in Axis I and II comorbidity between bipolar I and II disorders and major depressive disorder. Journal of Clinical Psychiatry, 67, 584-593.
Maremmani, I., Maremmani, A.G., Rugani, F., Rovai, L., Pacini, M., Bacciardi, S., ... Akiskal, H.S. (2012). Clinical presentations of substance abuse in bipolar heroin addicts at time of treatment entry. Annals of General Psychiatry, 11, 23. doi: 10.1186/1744-859X-11-23
Mazza, M., Mandelli, L., Di Nicola, M., Harnic, D., Catalano, V., Tedeschi, D., ... Janiri, L. (2009). Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up. Journal of Affective Disorders, 115, 27-35. doi: 10.1016/j.jad.2008.08.019
McElroy, S.L., Altshuler, L.L., Suppes, T., Keck, P.E. Jr, Frye, M.A., Denicoff, K.D., ... Post, R.M. (2001). Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. American Journal of Psychiatry, 158, 420-426.
Merikangas, K.R., Akiskal, H.S., Angst, J., Greenberg, P.E., Hirschfeld, R.M., Petukhova, M. y Kessler, R.C. (2007). Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Archives of General Psychiatry, 64, 543-552.
Merikangas, K.R., Herrell, R., Swendsen, J., Rössler, W., Ajdacic-Gross, V. y Angst, J. (2008). Specificity of bipolar spectrum conditions in the comorbidity of mood and substance use disorders: results from the Zurich cohort study. Archives of General Psychiatry, 65, 47-52. doi: 10.1001/archgenpsychiatry.2007.18
Merikangas, K.R., Jin, R., He, J.P., Kessler, R.C., Lee, S., Sampson, N.A., ... Zarkov, Z. (2011). Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Archives of General Psychiatry, 68, 241-251. doi: 10.1001/archgenpsychiatry.2011.12
Mitchell, J.D., Brown, E.S. y Rush, A.J. (2007). Comorbid disorders in patients with bipolar disorder and concomitant substance dependence. Journal of Affective Disorders, 102, 281-287.
Nallet, A., Weber, B., Favre, S., Gex-Fabry, M., Voide, R., Ferrero, F., ... Aubry, J.M. (2013). Screening for bipolar disorder among outpatients with substance use disorders. European Psychiatry, 28, 147-153.
Pacini, M., Maremmani, I., Vitali, M., Romeo, M., Santini, P., Vermeil, V. y Ceccanti, M. (2010). Cocaine Abuse in 448 Alcoholics: Evidence for a Bipolar Connection. Addictive Disorders & their Treatment, 9, 164–171.
Powers, R.L., Russo, M., Mahon, K., Brand, J., Braga, R.J., Malhotra, A.K. y Burdick, K.E. (2013). Impulsivity in bipolar disorder: relationships with neurocognitive dysfunction and substance use history. Bipolar Disorders, 15, 876-884. doi: 10.1111/bdi.12124
Regier, D.A., Farmer, M.E., Rae, D.S., Locke, B.Z., Keith, S.J., Judd, L.L. y Goodwin, F.K. (1990). Comorbidity of mental disorders with alcohol and other drug abuse: Result from the Epidemiologic Catchment Area (ECA) Study. The Journal of the American Medical Association, 264, 2511–2518.
Salloum, I.M., Cornelius, J.R., Douaihy, A., Kirisci, L., Daley, D.C. y Kelly, T.M. (2005). Patient characteristics and treatment implications of marijuana abuse among bipolar alcoholics: results from a double blind, placebo-controlled study. Addictive Behaviors, 30, 1702-1708.
Sheehan, D.V., Lecrubier, Y., Harnett-Sheehan, K., Janavs, J., Weiller, E. y Bonora, L.I. (1997). Reliability and validity of the MINI International Neuropsychiatric Interview (MINI): According to the SCID-P. European Psychiatry, 12, 232-241.
Sheehan, D.V., Lecrubier, Y., Sheehan, K.H., Amorim, P., Janavs, J., Weiller, E., Hergueta, T., ... Dunbar, G.C. (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, 59, 22-33.
Simon, N.M., Otto, M.W., Weiss, R.D., Bauer, M.S., Miyahara, S., Wisniewski, S.R., ... Pollack, M.H. (2004). Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD. Journal of Clinical Psychopharmacology, 24, 512-520.
Singh, M.K., Chang, K.D., Kelley, R.G., Cui, X., Sherdell, L., Howe, M.E., ... Reiss, A.L. (2013). Reward processing in adolescents with bipolar I disorder. Journal of the American Academy Child & Adolescent Psychiatry, 52, 68-83. doi: 10.1016/j.jaac.2012.10.004
Sonne, S.C. y Brady, K.T. (1999). Substance abuse and bipolar comorbidity. Psychiatry Clinics of North America, 22, 609-627.
Stewart, C. y El-Mallakh, R.S. (2007). Is bipolar disorder overdiagnosed among patients with substance abuse? Bipolar Disorders, 9, 646-648.
Tondo, L., Baldessarini, R.J., Hennen, J., Minnai, G.P., Salis, P., Scamonatti, L., ... Mannu, P. (1999). Suicide attempts in major affective disorder patients with comorbid substance use disorders. Journal of Clinical Psychiatry, 2, 63-69.
Trost, S., Diekhof, E.K., Zvonik, K., Lewandowski, M., Usher, J., Keil, M., ... Gruber, O. (2014). Disturbed anterior prefrontal control of the mesolimbic reward system and increased impulsivity in bipolar disorder. Neuropsychopharmacology, 39, 1914-1923. doi: 10.1038/npp.2014.39
Van Zaane, J., Van den Berg, B., Draisma, S., Nolen, W.A. y Van den Brink, W. (2012). Screening for bipolar disorders in patients with alcohol or substance use disorders: performance of the mood disorder questionnaire. Drug and Alcohol Dependence, 124, 235-241. doi: 10.1016/j.drugalcdep.2012.01.018
Weaver, T., Madden, P., Charles, V., Stimson, G., Renton, A. y Tyrer, P. (2003). Comorbidity of substance misuse and mental illness in community mental health and substance misuse services. British Journal of Psychiatry, 183, 304–313.
Yatham, L.N., Kauer-Sant’Anna, M., Bond, D.J., Lam, R.W. y Torres, I. (2009). Course and outcome after the first manic episode in patients with bipolar disorder: Prospective 12-month data from the systematic treatment optimization program for early mania project. Canadian Journal of Psychiatry, 54, 105-112.